CenterVue was established in 2008 in Italy with the support of M31, a European venture incubator. It opened a US subsidiary in Silicon Valley in 2011. Its products are aimed to prevent sight-threatening pathologies such as Diabetic Retinopathy and age-related Macular Degeneration, which are on the rise in the western world due to aging and dietary trends. CenterVue integrates the most advanced technologies to develop superior diagnostic instruments for eye care.

The competences of CenterVue’s design team span highly specialized fields such as optical design, image processing and computer vision software, microelectronics design, industrial design, patient-machine interface.

CenterVue’s solutions integrate seamlessly with state-of-the art telemedicine packages and with CenterVue’s proprietary telemedicine platform, the Eye Knowledge Network. A privately owned company, CenterVue combines the agility of a startup with the solid structure of an established organization: it features in-house research, product development, quality management and regulatory affairs, marketing, sales and post sales assistance.

Its strengths lie in its intellectual property and in the 120 men year of industry experience of its executives and researchers.